Inventor · disambiguated record
Matthias Urmann
Also filed as: URMANN MATTHIAS
32 granted patents·6 pending applications·184 citations·filing 2002–2010
95Inventor score
Top patents by PatentIndex Score
38 records- 0193US8735586B2Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazolesALONSO JORGE·Filed 2009·Granted May 27, 2014·34 cites·12 claims
- 0292US7772252B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 0391US8173674B2Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticalsKEIL STEFANIE·Filed 2009·Granted May 8, 2012·25 cites·24 claims
- 0490US7465806B2Pyrrole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Dec 16, 2008·18 cites·9 claims
- 0588US8188282B2Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazolesALONSO JORGE·Filed 2009·Granted May 29, 2012·11 cites·20 claims
- 0688US7317027B2Azaindole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jan 8, 2008·26 cites·10 claims
- 0784US7365088B2Indazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Apr 29, 2008·25 cites·11 claims
- 0878US7709481B2Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticalsSANOFI AVENTIS·Filed 2008·Granted May 4, 2010·4 cites·30 claims
- 0977US7449560B2Phosophoinositoglycan binding proteinsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Nov 11, 2008·2 cites·5 claims
- 1076US8026375B2Transition metal catalyzed synthesis of N-aminoindolesSANOFI AVENTIS·Filed 2009·Granted Sep 27, 2011·2 cites·11 claims
- 1174US8716317B2Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticalsKEIL STEFANIE·Filed 2009·Granted May 6, 2014·2 cites·27 claims
- 1274US7655679B2Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositionsSANOFI AVENTIS·Filed 2008·Granted Feb 2, 2010·2 cites·10 claims
- 1374US7550469B2Heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2006·Granted Jun 23, 2009·3 cites·5 claims
- 1471US8283476B2Transition metal catalyzed synthesis of 2H-indazolesHALLAND NIS·Filed 2009·Granted Oct 9, 2012·2 cites·1 claims
- 1569US7186724B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Granted Mar 6, 2007·4 cites·40 claims
- 1667US7049416B2Phosophoinositoglycan binding proteinsSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted May 23, 2006·2 cites·9 claims
- 1762US7772257B2Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their useSANOFI AVENTIS·Filed 2009·Granted Aug 10, 2010·0 cites·18 claims
- 1861US8946212B2Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticalsKEIL STEFANIE·Filed 2009·Granted Feb 3, 2015·0 cites·17 claims
- 1961US2008280946A1Azaindole-Derivatives As Factor Xa InhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 2059US7851493B2Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticalsSANOFI AVENTIS·Filed 2009·Granted Dec 14, 2010·0 cites·21 claims
- 2158US8329725B2Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticalsKEIL STEFANIE·Filed 2009·Granted Dec 11, 2012·0 cites·21 claims
- 2258US7612104B2Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their useSANOFI AVENTIS·Filed 2008·Granted Nov 3, 2009·0 cites·17 claims
- 2357US7521445B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2007·Granted Apr 21, 2009·0 cites·19 claims
- 2456US7834030B2Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereofSANOFI AVENTIS·Filed 2008·Granted Nov 16, 2010·0 cites·32 claims
- 2555US2010216988A1Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazolesSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 2650US8420812B2Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonatesRKYEK OMAR·Filed 2009·Granted Apr 16, 2013·0 cites·15 claims
- 2750US7910612B24-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic useSANOFI AVENTIS·Filed 2008·Granted Mar 22, 2011·0 cites·15 claims
- 2850US7858647B2N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic useSANOFI AVENTIS·Filed 2008·Granted Dec 28, 2010·0 cites·24 claims
- 2950US2005107389A1Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 3049US7683181B2Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereofSANOFI AVENTIS·Filed 2008·Granted Mar 23, 2010·0 cites·17 claims
- 3148US8088925B2Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitorsWAGNER MICHAEL·Filed 2007·Granted Jan 3, 2012·0 cites·3 claims
- 3245US2007179122A1Beta-Aminoacid-Derivatives As Factor Xa InhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 3344US8487109B2Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylatesRKYEK OMAR·Filed 2009·Granted Jul 16, 2013·0 cites·14 claims
- 3444US7741341B2Benzimidazole-derivatives as factor Xa inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Jun 22, 2010·0 cites·19 claims
- 3543US8748483B2Use of substituted pyranone acid derivatives for the treatment of metabolic syndromeBRUMMERHOP HARM·Filed 2009·Granted Jun 10, 2014·0 cites·5 claims
- 3643US2004030137A1Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsFiled 2002·Application pending·0 cites
- 3734US8344004B2Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticalsSANOFI SA·Filed 2010·Granted Jan 1, 2013·0 cites·14 claims
- 3834US2003229066A1Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligandsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Urmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →